Details for New Drug Application (NDA): 017503
✉ Email this page to a colleague
The generic ingredient in COMBIPRES is chlorthalidone; clonidine hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.
Summary for 017503
Tradename: | COMBIPRES |
Applicant: | Boehringer Ingelheim |
Ingredient: | chlorthalidone; clonidine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 15MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 15MG;0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 15MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Apr 10, 1984 | TE: | RLD: | Yes |
Expired US Patents for NDA 017503
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | COMBIPRES | chlorthalidone; clonidine hydrochloride | TABLET;ORAL | 017503-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | COMBIPRES | chlorthalidone; clonidine hydrochloride | TABLET;ORAL | 017503-003 | Apr 10, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | COMBIPRES | chlorthalidone; clonidine hydrochloride | TABLET;ORAL | 017503-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription